Predictmedix Preps for Big Year Ahead, as Demand for its Contactless Screening Devices sees Ramp Up of Partnerships, M&A and Strategic Financing

Predictmedix is an Artificial Intelligence company that has developed fast, non-invasive, contactless screening devices that detect infectious diseases, impairment and even mental illness at any location where mass amounts of people gather, such as:

• Hospitals
• Stadiums
• Airports
• Malls
• Government Buildings
• Office Complexes

These screeners are fully automated and intelligent, so they don’t need personnel to operate them. They determine the probability of a person being infected with illnesses such as COVID-19, so safety protocols can be initiated.

Earlier this month, the AI firm penned a major strategic partnership with Juiceworks and Connectus Global to deploy its Safe Entry Stations nationwide.

That news came during an increasingly busy time for $PMED, which has included:

• An LOI to acquire AI-powered tech firm Symp2Pass
• The engagement of investment banking firm Kingswood Capital Markets in preparation for NASDAQ listing
• Major partnerships
• Strategic financing developments

You’re going to want to get comfy for this chat with Predictmedix COO & Director Rahul Kushwah: